As of now, he was 8 years old and his insulin dosage was 1.1 IU/kg/d. Even under fluconazole therapy, he developed oral mucocutaneous Candida fungi twice every month, but he did not develop recurrent viral or bacterial infections. He was given antituberculosis drugs (isoniazide, rifampicin) for tuberculosis infection. The liver function was normal at the last follow-up, and the HbA1c was 6.5%. Ruxolitinib was recommended to the patient's parents, but they refused because of concerns about side effects.